<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03051308</url>
  </required_header>
  <id_info>
    <org_study_id>BAVUvsUW</org_study_id>
    <nct_id>NCT03051308</nct_id>
  </id_info>
  <brief_title>University of Wisconsin Solution Versus New Parathyroid Transport Solution for Parathyroid Allotransplantation</brief_title>
  <official_title>University of Wisconsin Solution Versus New Parathyroid Transport Solution for Parathyroid Allotransplantation: Effects on Calcium Sensing and Vitamin D Receptor During Cold Ischemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SB Istanbul Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SB Istanbul Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare the functionality of new parathyroid transport solution (NPTS) with University of
      Wisconsin Solution (UW) on parathyroid glands. Also assess its effects on cell viability,
      parathormone (PTH) secretion, calcium-sensing receptor (CaSR) and vitamin D receptor (VDR)
      levels during cold ischemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parathormone (PTH) and vitamin D are two critical hormonal regulators of calcium homeostasis.
      There is an important relationship between the PTH release and vitamin D receptor for
      controlling hormonal systems. Also calcium-sensing receptor plays a crucial role in
      regulating parathormone secretion which means controlling the calcium-dependent systemic ion
      homeostasis.

      Cold ischemia protects organs and tissues by slowing their metabolism. The cold ischemia of
      the transplant tissue is a very important process. The University of Wisconsin (UW) solution
      substantially improves graft preservation and consequently increases patient survival. The
      researchers newly developed NPTS for transportation of parathyroid glands.

      For the comparision the researchers measured the parathyroid cell viability and the calcium
      sensing and vitamin D receptor density of the parathyroid cells at the 0, 6, 12 and 24 hours
      of cold ischemia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2017</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cell viability of Parathyroid cells after isolation process</measure>
    <time_frame>0 hour</time_frame>
    <description>After removal of hyperplastic parathyroid glands, each gland will keep in ice cold NPTS and UW solution for transportation to laboratory.
Then the investigators will measure the viability of Parathyroid cells after isolation process.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cell viability of Parathyroid cells after 6 hour of cold ischemia</measure>
    <time_frame>6 hour</time_frame>
    <description>After removal of hyperplastic parathyroid glands, each gland will keep in ice cold NPTS and UW solution for transportation to laboratory. After 6 hours the investigators will measure the viability of Parathyroid cells after isolation process.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cell viability of Parathyroid cells after 12 hour of cold ischemia</measure>
    <time_frame>12 hour</time_frame>
    <description>After removal of hyperplastic parathyroid glands, each gland will keep in ice cold NPTS and UW solution for transportation to laboratory. After 12 hours the investigators will measure the viability of Parathyroid cells after isolation process.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cell viability of Parathyroid cells after 18 hour of cold ischemia</measure>
    <time_frame>18 hour</time_frame>
    <description>After removal of hyperplastic parathyroid glands, each gland will keep in ice cold NPTS and UW solution for transportation to laboratory. After 18 hours the investigators will measure the viability of Parathyroid cells after isolation process.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cell viability of Parathyroid cells after 24 hour of cold ischemia</measure>
    <time_frame>24 hour</time_frame>
    <description>After removal of hyperplastic parathyroid glands, each gland will keep in ice cold NPTS and UW solution for transportation to laboratory. After 24 hours the investigators will measure the viability of Parathyroid cells after isolation process.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parathormone Release of Parathyroid Cells</measure>
    <time_frame>1 day</time_frame>
    <description>The investigators will measure the parathormone level from cultured parathyroid cells</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">7</enrollment>
  <condition>Parathyroid Allotransplantation</condition>
  <arm_group>
    <arm_group_label>First Application in Hour 0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Viability, Calcium-sensing receptor, Vitamin D receptor and parathormone levels of Parathyroid cells (10^7 cells) at 'First Application in Hour 0' non-cold ischemia tissue group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Application in Hour 6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Viability, Calcium-sensing receptor, Vitamin D receptor and parathormone levels of Parathyroid cells (10^7 cells) at 'First Application in Hour 6' cold ischemic tissue group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Application in Hour 12</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Viability, Calcium-sensing receptor, Vitamin D receptor and parathormone levels of Parathyroid cells (10^7 cells) at 'First Application in Hour 12' cold ischemic tissue group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Application in Hour 18</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Viability, Calcium-sensing receptor, Vitamin D receptor and parathormone levels of Parathyroid cells (10^7 cells) at 'First Application in Hour 18' cold ischemic tissue group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Application in Hour 24</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Viability, Calcium-sensing receptor, Vitamin D receptor and parathormone levels of Parathyroid cells (10^7 cells) at 'First Application in Hour' 24 cold ischemic tissue group</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>NPT and UW Solution</intervention_name>
    <description>Tissue preservation solutions for transplantation</description>
    <arm_group_label>First Application in Hour 0</arm_group_label>
    <arm_group_label>First Application in Hour 6</arm_group_label>
    <arm_group_label>First Application in Hour 12</arm_group_label>
    <arm_group_label>First Application in Hour 18</arm_group_label>
    <arm_group_label>First Application in Hour 24</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have parathyroid hyperplasia due to chronic renal failure.

        Exclusion Criteria:

          -  Patients who refused to join the study

          -  Patients younger than 18 years and older than 80 years.

          -  Patients who have hepatitis B,

          -  Patients who have hepatitis C,

          -  Patients who have human immunodeficiency virus (HIV).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erhan Aysan, Prof. M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Bezmialem Vakif University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erhan Aysan, Prof. M.D.</last_name>
    <phone>+902124531700</phone>
    <phone_ext>2465</phone_ext>
    <email>erhanaysan@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Beyza Goncu, Msc</last_name>
    <phone>+902124531700</phone>
    <phone_ext>1465</phone_ext>
    <email>bsgoncu@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bezmialem Vakif University Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erhan Aysan, Prof. M.D.</last_name>
      <phone>+902124531700</phone>
      <phone_ext>2465</phone_ext>
      <email>erhanaysan@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Beyza Goncu, Msc</last_name>
      <phone>+902124531700</phone>
      <phone_ext>1465</phone_ext>
      <email>bsgoncu@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation. 1988 Apr;45(4):673-6. Review.</citation>
    <PMID>3282347</PMID>
  </reference>
  <reference>
    <citation>Southard JH, van Gulik TM, Ametani MS, Vreugdenhil PK, Lindell SL, Pienaar BL, Belzer FO. Important components of the UW solution. Transplantation. 1990 Feb;49(2):251-7.</citation>
    <PMID>1689516</PMID>
  </reference>
  <reference>
    <citation>Guibert EE, Petrenko AY, Balaban CL, Somov AY, Rodriguez JV, Fuller BJ. Organ Preservation: Current Concepts and New Strategies for the Next Decade. Transfus Med Hemother. 2011;38(2):125-142. Epub 2011 Mar 21.</citation>
    <PMID>21566713</PMID>
  </reference>
  <reference>
    <citation>Voigt MR, DeLario GT. Perspectives on abdominal organ preservation solutions: a comparative literature review. Prog Transplant. 2013 Dec;23(4):383-91. doi: 10.7182/pit2013100. Review.</citation>
    <PMID>24311404</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2017</study_first_submitted>
  <study_first_submitted_qc>February 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2017</study_first_posted>
  <last_update_submitted>February 8, 2017</last_update_submitted>
  <last_update_submitted_qc>February 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>SB Istanbul Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Erhan Aysan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Parathyroid cell viability</keyword>
  <keyword>Ischemia</keyword>
  <keyword>Parathyroid allotransplantation</keyword>
  <keyword>Vitamin D Receptor</keyword>
  <keyword>Calcium Sensing Receptor</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

